We report on a series of six patients diagnosed as anti-MAG polyneuropathy treated with rituximab. Nine months after the infusion of rituximab, sensory deficiency considered through the INCAT sensory score was improved in 5 patients and functional disability quantified by the overall neuropathy limitation scale was improved in 3 patients....
-
September 2011 (v1)Journal articleUploaded on: December 4, 2022
-
2015 (v1)Journal article
ObjectivesThe current study aimed at describing the distribution and characteristics of malignancy related deaths in human immunodeficiency virus (HIV) infected patients in 2010 and at comparing them to those obtained in 2000 and 2005.MethodsData were obtained from three national surveys conducted in France in 2010, 2005 and 2000. The...
Uploaded on: March 26, 2023 -
December 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
February 2010 (v1)Journal article
BACKGROUND: Little is known about the causes of death in human immunodeficiency virus (HIV)-infected women in the era of combination antiretroviral therapy (ART). METHODS: In the French nationwide Mortalité 2000 and 2005 surveys, physicians reported causes of deaths in HIV-infected adults in 2000 and 2005, using a standardized questionnaire. We...
Uploaded on: October 11, 2023 -
February 2010 (v1)Journal article
BACKGROUND: Little is known about the causes of death in human immunodeficiency virus (HIV)-infected women in the era of combination antiretroviral therapy (ART). METHODS: In the French nationwide Mortalité 2000 and 2005 surveys, physicians reported causes of deaths in HIV-infected adults in 2000 and 2005, using a standardized questionnaire. We...
Uploaded on: December 3, 2022 -
December 2016 (v1)Journal article
The main objective of the current study was to develop and validate a French exercise stereotype scale for people living with HIV (PLHIV) in order to gain visibility to the possible barriers and facilitators for exercise in PLHIV and thus enhance their quality of life.
Uploaded on: December 4, 2022 -
August 2022 (v1)Journal article
Overweight is increasingly prevalent in people living with HIV (PLWH), and is a high risk factor for metabolic disorders in this population. PLWH co-infected with hepatitis C virus (HCV) have a higher risk of metabolic disorders than their mono-infected counterparts. The putative relationship between cannabis use and body weight found in the...
Uploaded on: April 14, 2023 -
May 9, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
December 29, 2021 (v1)Report
Rapport de l'enquête « Science Ouverte » menée à l'ANRS|Maladies infectieuses émergentes en 2021 Accès ouvert aux publications-Partage des données de la recherche-Connaissances/expérience/besoins/attentes
Uploaded on: December 3, 2022 -
2014 (v1)Journal article
In HCV genotype 1-infected patients with HIV co-infection, tritherapy [HCV protease inhibitors (PIs) plus peg-interferon and ribavirin] has been shown to have an increased rate of sustained virological response. However, complex drug-to-drug interactions and tolerability issues remain a concern. Methods: Under the auspices of four French...
Uploaded on: December 4, 2022 -
April 1, 2019 (v1)Journal article
Background: Hepatitis C virus (HCV) and HIV infections are associated with higher risk of autoimmune diseases and T-cell dysfunction.Setting: We evaluate prevalence and factors associated with the presence of autoimmune antinuclear (ANA), anti–smooth muscle actin (aSMA), and anti–liver kidney microsome (aLKM1) antibodies (Ab) in...
Uploaded on: December 4, 2022 -
March 12, 2012 (v1)Journal article
ABSTRACT: BACKGROUND: Treatment for the hepatitis C virus (HCV) may be delayed significantly in HIV/HCV co-infected patients. Our study aims at identifying the correlates of access to HCV treatment in this population. METHODS: We used 3-year follow-up data from the HEPAVIH ANRS-CO13 nationwide French cohort which enrolled patients living with...
Uploaded on: December 4, 2022 -
September 2017 (v1)Journal article
BACKGROUND AND AIMS:Few data exist on changes to substance use patterns before and after hepatitis C virus (HCV) treatment. We used longitudinal data of HIV-HCV co-infected individuals to examine whether receiving pegylated interferon (Peg-IFN)-based therapy irrespective of HCV clearance could modify tobacco, cannabis and alcohol use.DESIGN:A...
Uploaded on: December 4, 2022